Extended-release opioid agonists and antagonists represent an alternative treatment strategy for opioid use disorder. However their value is low for the money, according to this summary of an ICER analysis published in JMCP.
Managed Care Pharmacy Issues
Stay updated on the latest managed care pharmacy issues with our comprehensive resources. Explore key topics, current challenges, and expert insights to enhance your practice and advocate for better health care solutions. Learn more about our advocacy with our pharmacy practice positions.